JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients

  • 0Department of Immunology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
Cells +

|

January 8, 2025

|

January 8, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Adipose-derived mesenchymal stem cells (ADSCs) show promise for treating idiopathic pulmonary fibrosis (IPF). Studies show ADSCs reduce fibrosis markers and improve lung function in preclinical models, offering new hope for IPF patients.

Area Of Science

  • Regenerative Medicine
  • Pulmonary Medicine
  • Stem Cell Biology

Background

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
  • Current research seeks novel therapies, with stem cells emerging as a potential avenue.
  • Adipose-derived mesenchymal stem cells (ADSCs) offer advantages over other stem cell sources for IPF treatment.

Purpose Of The Study

  • To investigate the therapeutic potential of ADSCs for IPF.
  • To evaluate the efficacy of ADSCs in reducing fibrosis in preclinical models of IPF.

Main Methods

  • Co-culture of human IPF lung fibroblasts (LFs) with ADSCs.
  • Analysis of fibrosis-related gene expression and ERK signaling pathway activation.
  • Administration of ADSCs in bleomycin-induced pulmonary fibrosis mouse models.
  • Evaluation in a humanized mouse model with IPF LFs.

Main Results

  • ADSCs reduced fibrosis-related gene expression in IPF LFs.
  • ADSCs inhibited ERK signaling pathway activation via PTPRR upregulation.
  • Intravascular ADSC administration improved lung fibrosis in mouse models, reducing collagen deposition and α-SMA expression.
  • ADSCs demonstrated efficacy in both standard and humanized mouse models of lung fibrosis.

Conclusions

  • ADSCs represent a promising therapeutic candidate for IPF.
  • ADSC therapy may offer a novel treatment strategy for idiopathic pulmonary fibrosis.
  • Further research into ADSC mechanisms and clinical application is warranted.

Keywords: